Skip to main content
. 2021 Mar 17;26(6):1666. doi: 10.3390/molecules26061666

Figure 1.

Figure 1

Figure 1

Effects of berberine (BBR) and/or cisplatin (DDP) on MG-63 and HBMSC cell viability. (A) Viability of MG-63 cells after treatment with different concentrations of DDP for 24 or 48 h. (B) Viability of MG-63 cells after treatment with different concentrations of BBR for 24 or 48 h. (C) Viability of HBMSC cells after treatment with different concentrations of DDP for 24 or 48 h. (D) Viability of HBMSC cells after treatment with different concentrations of BBR for 24 or 48 h. (E) Viability of MG-63 cells after treatment with BBR and/or DDP for 24 h. (F) Viability of MG-63 cells after treatment with BBR and/or DDP for 48 h. (G) Viability of HBMSC cells after treatment with BBR and/or DDP for 24 h. (H) Viability of HBMSC cells after treatment with BBR and/or DDP for 48 h. The data are presented as the mean ± SD of three separate experiments; * p < 0.05 ** p < 0.01, compared with the control group.